S&P 500 Futures
(0.12%) 5 137.50 points
Dow Jones Futures
(0.08%) 38 472 points
Nasdaq Futures
(0.20%) 17 881 points
Oil
(-0.24%) $83.65
Gas
(1.66%) $1.955
Gold
(0.13%) $2 350.30
Silver
(0.48%) $27.67
Platinum
(1.52%) $936.10
USD/EUR
(-0.18%) $0.933
USD/NOK
(-0.28%) $10.99
USD/GBP
(-0.29%) $0.798
USD/RUB
(1.16%) $92.94

实时更新: MaxCyte, Inc. [MXCT]

交易所: NASDAQ Global Select 部门: Healthcare 工业: Medical - Devices
BUY
83.33%
return 7.40%
SELL
0.00%
return 9.90%
最后更新时间27 Apr 2024 @ 04:00

0.54% $ 3.71

购买 107564 min ago

@ $4.78

发出时间: 15 Feb 2024 @ 01:00


回报率: -22.38%


上一信号: Feb 13 - 23:49


上一信号: 出售


回报率: -0.46 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering...

Stats
今日成交量 340 219
平均成交量 563 159
市值 386.32M
EPS $0 ( 2024-03-12 )
下一个收益日期 ( $-0.140 ) 2024-05-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -10.03
ATR14 $0.00200 (0.05%)
Insider Trading
Date Person Action Amount type
2024-03-26 Johnston John Joseph Buy 5 000 Common Stock
2024-03-26 Johnston John Joseph Sell 5 000 Common Stock
2024-03-26 Johnston John Joseph Sell 5 000 Stock Option (right to buy)
2024-03-15 Ross Thomas M. Buy 100 000 Employee Stock Option (right to buy)
2024-03-15 Ross Thomas M. Buy 25 000 Common Stock
INSIDER POWER
40.18
Last 100 transactions
Buy: 1 609 082 | Sell: 743 053

音量 相关性

長: 0.19 (neutral)
短: 0.75 (moderate)
Signal:(51.031) Neutral

MaxCyte, Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

MaxCyte, Inc. 相关性 - 货币/商品

The country flag 0.46
( neutral )
The country flag 0.25
( neutral )
The country flag 0.00
( neutral )
The country flag 0.23
( neutral )
The country flag 0.00
( neutral )
The country flag -0.50
( weak negative )

MaxCyte, Inc. 财务报表

Annual 2023
营收: $41.29M
毛利润: $32.56M (78.86 %)
EPS: $-0.370
FY 2023
营收: $41.29M
毛利润: $32.56M (78.86 %)
EPS: $-0.370
FY 2022
营收: $44.26M
毛利润: $39.16M (88.48 %)
EPS: $-0.190
FY 2021
营收: $33.89M
毛利润: $30.25M (89.24 %)
EPS: $-0.210

Financial Reports:

No articles found.

MaxCyte, Inc.

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。